Skip to main content

Relevant Literature

The YODA Project recommends the following articles for those interested in learning more about the data sharing field. Many of these articles aided in the development of the YODA Project policies and procedures. This is not intended to be a comprehensive list, and additional resources will be added over time.

NIH Data Sharing Resources

NIH Sharing Policies and Related Guidance on NIH-Funded Research Resources
Plan for Increasing Access to Scientific Publications and Digital Scientific Data from NIH Funded Scientific Research
NIH Data Sharing Repositories

National Academy of Medicine

Institute of Medicine. Sharing Clinical Trial Data: Maximizing Benefits, Minimizing Risk. Washington, DC, The National Academies Press, 2015.
Institute of Medicine. Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities. Washington, DC, The National Academies Press, 2014.
Institute of Medicine. Vaccine Safety Research, Data Access, and Public Trust. Washington, DC, The National Academies Press, 2005.

Data Sharing Policies and Progress

Zarin DA, Tse T, Williams RJ, Carr S. Trial Reporting in The Final Rule. NEJM. September 16, 2016.
The Economist. Clinical Trial Publishing Game. October 6, 2015.
University of Bath. Funders’ data policies.
Stewart LA, Clarke M, Rovers M, Riley RD, Simmonds M, Stewart G, Tierney JF. Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data: The PRISMA-IPD Statement. JAMA. 2015;313:1657-1665.
Moorthy VS, Karam G, Vannice KS, Kieny M. Rationale for WHO’s New Position Calling for Prompt Reporting and Public Disclosure of Interventional Clinical Trial Results. PLOS Med. 2015;12.
Mitka M. Clinical Trial Data: Share and Share Alike? JAMA. 2015;313:881-882.
Zarin DA, Tse T, Sheehan J. The Proposed Rule for U.S. Clinical Trial Registration and Results Submission. N Engl J Med. 2015;372:174-180.
European Medicines Agency. European Medicines Agency policy on publication of clinical data for medicinal products for human use: POLICY/0070. October 2, 2014.
Varnai P, Rentel MC, Simmonds P, Sharp TA, Mostert B, de Jongh, T. Assessing the research potential of access to clinical trial data.  A report to the Wellcome Trust. Study led by Technopolis Group (UK), 2014.
Bonini S, Eichler HG, Wathion N, Rasi G. Transparency and the European Medicines Agency- Sharing of Clinical Trial Data. N Engl J Med. 2014;371:2452-2455.
Steinbrook R. The European Medicines Agency and the Brave New World of Access to Clinical Trial Data. JAMA Internal Med. 2013;173:373-374.
Doshi P, Goodman SN, Ioannidis JA. Raw Data from Clinical Trials: Within Reach? Trends Pharm Sci. 2013;34:645-647.
Pharmaceutical Research and Manufacturers of America [PhRMA] and European Federation of Pharmaceutical Industries and Associations [EFPIA]. Principles for Responsible Clinical Trial Data Sharing: Our Commitment to Patients and Researchers. July 18, 2013.
Doshi P, Jefferson T. The First 2 Years of the European Medicines Agency’s Policy on Access to Documents: Secret No Longer. JAMA Internal Med. 2013;173:380-382.
Vickers AJ. Making Raw Data More Widely Available. BMJ. 2011;342:d2323.
European Medicines Agency. European Medicines Agency policy on access to documents (related to medicinal products for human and veterinary use): POLICY/0043. November 30, 2010.

Approaches to Data Sharing

Tudur Smith C, Hopkins C, Sydes M, Woolfall K, Clarke M, Murray G, Williamson P. Good Practice Principles for Sharing Individual Participant Data from Publicly Funded Clinical Trials. April 2015.
El Emam K, Rodgers S, Malin B. Anonymising and Sharing Individual Patient Data. BMJ. 2015;350:h1139.
Sydes MR, Johnson AL, Meredith SK, Rauchenberger M, South A, Parmar MKB. Sharing Data from Clinical Trials: The Rationale for a Controlled Access Approach. Trials. 2015;16:104.
Kush R, Goldman M. Fostering Responsible Data Sharing through Standards. N Engl J Med. 2014;370:2163-2165.
Wilhelm EE, Oster E, Shoulson I. Approaches and Costs for Sharing Clinical Research Data. JAMA. 2014;311:1201-1202.
Ioannidis JA, Greenland S, Hlatky MA, Khoury MJ, Macleod MR, Moher D, Schulz KF, Tibshirani R. Increasing Value and Reducing Waste in Research Design, Conduct, and Analysis. Lancet. 2014;383:166-175.
Mello MM, Francer JK, Wilenzick M, Teden P, Bierer BE, Barnes M. Preparing for Responsible Sharing of Clinical Trial Data. NEJM. 2013;369:1651-1658.
Berman F, Cerf V. Who Will Pay for Public Access to Research Data? Science. 2013;341:616-617.
Tucker M. How Should Clinical Trial Data be Shared? BMJ. 2013;347:f4465.
Eichler HG, Abadie E, Breckenridge A, Leufkens H, Rasi G. Open Clinical Trial Data for All? A View from Regulators. PLOS Med. 2012;9:e1001202.
Spertus JA. The Double-Edged Sword of Open Access to Research Data. Circ Cardiovasc Qual Outcomes. 2012;5:143-144.
Hrynaszkiewicz I, Norton ML, Vickers AJ, Altman DG. Preparing Raw Clinical Data for Publication: Guidance for Journal Editors, Authors, and Peer Reviewers. BMJ. 2010;340:c181.
Hrynaszkiewicz I, Altman DG. Towards Agreement on Best Practice for Publishing Raw Clinical Trial Data. Trials. 2009;10:17.
Piwowar HA, Becich MJ, Bilofsky H, Crowley RS. Towards a Data Sharing Culture: Recommendations for Leadership from Academic Health Centers. PLoS Med. 2008;5:e183.

Importance of Transparency

Scherer RW, Ugarte-Gil C, Schmucker C, Meerpohl JJ. Authors Report Lack of Time as Main Reason for Unpublished Research Presented at Biomedical Conferences: a Systematic Review. J Clin Epidemiol. Epub February 13, 2015.
Vale CL, Rydzewska LHM, Rovers MM, Emberson JR, Gueyffier F, Stewart LA. Uptake of Systematic Reviews and Meta-Analyses Based on Individual Participant Data in Clinical Practice Guidelines: Descriptive Study. BMJ. 2015;350:h1088.
Ebrahim S, Sohani ZN, Montoya L, Agarwal A, Thorlund K, Mills EJ, Ioannidis JA. Reanalyses of Randomized Clinical Trial Data. JAMA. 2014;312:1024-1032.
Manzoli L, Flacco ME, D’Addario M, Capasso L, De Vito C, Marzuillo C, Villari P, Ioannidis JA. Non-Publication and Delayed Publication of Randomized Trials on Vaccines: Survey. BMJ. 2014;348:g3058.
Zarin DA. Participant-Level Data and the New Frontier in Trial Transparency. N Engl J Med. 2013;369:468-469.
Eichler HG, Pétavy F, Pignatti F, Rasi G. Access to Patient-Level Trial Data- A Boon to Drug Developers. N Engl J Med. 2013;369:1577-1579.
Christakis DA, Zimmerman FJ. Rethinking Reanalysis. JAMA. 2013;310:2499-2500.
Rodwin MA, Abramson JD. Clinical Trial Data as a Public Good. JAMA. 2012;308:871-872.
Gøtzsche PC. Strengthening and Opening Up Health Research by Sharing Our Raw Data. Circ Cardiovasc Qual Outcomes. 2012;5:236-237.
Alsheikh-Ali AA, Qureshi W, Al-Mallah MH, Ioannidis JA. Public Availability of Published Research Data in High-Impact Journals. PLOS One. 2011;6:e24357.
Gøtzsche PC. Why We Need Easy Access to All Data from All Clinical Trials and How to Accomplish it. Trials. 2011;12:249.
Savage CJ, Vickers AJ. Empirical Study of Data Sharing by Authors Publishing in PLoS Journals. PLoS ONE. 2009;4:e7078.
Zarin DA, Ide NC, Tse T, Harlan WR, West JC, Lindberg DB. Issues in the Registration of Clinical Trials. JAMA. 2007;297:2112-2120.
Vickers AJ. Whose Data Set Is It Anyway? Sharing Raw Data from Randomized Trials. Trials. 2006;7:15.

Patient Perspective

Lomas A. I’m a Patient: Show Me the Trial Data. BMJ. 2013;346:f2336.

Data Request Dashboard


No data requests found. Click here to generate a new one.